AtCor sends investors' pulses racing

AtCor's full-year guidance was strong and is encouraging for the blood pressure medical device maker's future.

AtCor Medical (ACG) share price enjoyed its second best one-day surge on record after it confirmed that it will report a maiden full year profit when it releases its results next month.

AtCor, which developed a blood pressure and arterial stiffness measuring device, said 2012-13 sales is expected to surge 40% to $9 million and full year profit will range between $2.7 million to $2.9 million.

{{content.question}}

{{ twilioFailed ? 'SMS Code Failed to Send…' : 'SMS Code Sent…' }}

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa
Mastercard

The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device


Register as a new member

(using a different email)

Related Articles